Chrysoeriol: a natural RANKL inhibitor targeting osteoclastogenesis and ROS regulation for osteoporosis therapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hao,Luo

第一单位： Orthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.

作者： Hao,Luo ^[1] ; Sijian,Lin ^[2] ; Hao,Lv ^[1] ; Wen,Tan ^[1] ; Junlong,Zhong ^[1] ; Jiachao,Xiong ^[1] ; ZhiMing,Liu ^[1] ; Qin,Wu ^[1] ; Ming,Chen ^[3] ; Kai,Cao ^[4]

作者单位： Orthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China. ^[1] The Rehabilitation Medicine Department, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China. ^[2] Orthopedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, China. ndyfy01837@ncu.edu.cn. ^[3] The Key Laboratory of Spine and Spinal Cord Disease of Jiangxi Province, Nanchang, 330006, China. caokai@ncu.edu.cn.;Department of Orthopedics, Affiliated Rehabilitation Hospital of Nanchang University, Nanchang, 330002, China. caokai@ncu.edu.cn. ^[4]

关键词 Chrysoeriol NFATc1 Osteoclast Osteoporosis ROS

DOI 10.1007/s00210-024-03714-3

PMID 39755833

发布时间 2025-01-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Naunyn-Schmiedeberg's archives of pharmacology

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Chrysoeriol: a natural RANKL inhibitor targeting osteoclastogenesis and ROS regulation for osteoporosis therapy.

Naunyn-Schmiedeberg's archives of pharmacology

相似文献

Naunyn-Schmiedeberg's archives of pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Chrysoeriol: a natural RANKL inhibitor targeting osteoclastogenesis and ROS regulation for osteoporosis therapy.

Naunyn-Schmiedeberg's archives of pharmacology

相似文献

Naunyn-Schmiedeberg's archives of pharmacology

相关期刊

检索历史清除